Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
LXH254 Combination for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
San Diego, California
This trial is testing the safety and tolerability of a new drug, LXH254, when combined with either LTT462 or trametinib or ribociclib. The goal is to identify a recommended dose and regimen for this new drug combination.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.